1. Introduction of Compound Libraries Market Applications
According to the applications, compound libraries can be divided into High Throughput Screening, Common Drug Design, Medicinal Chemistry and Research, Other Chemical Research.
High Throughput Screening: High-throughput screening (HTS) is one of the newest techniques used in drug design and can be applied in biological and chemical sciences. Specifically, high throughput screening (HTS) is the use of automated equipment to rapidly test samples for biological activity at the model organism, cellular, pathway, or molecular level using automated methods. The number of samples can be thousands to millions. It is a process of screening and assaying a large number of biological modulators and effectors against selected and specific targets. High-throughput screening (HTS) is widely used by industrial scientists and academic researchers.
Common Drug Design: Drug design is a complex pharmaceutical science with a long history, which is the inventive process of finding new medications based on the knowledge of a biological target. During the process, it relies on prior knowledge of the structure, function, and mechanism of the target, to improve the drug design efficiency. With the development of drug design areas. Currently, advanced technologies such as artificial intelligence and automation have been used in the process of drug design.
Medicinal Chemistry and Research: Medicinal chemistry, based on synthetic organic chemistry, is the discipline of combining small molecules to create new ones by scientists. It involves the creation and refinement of molecules to create or improve drugs. It also may involve the synthesis of new compounds, investigations of their relationships between the structure of natural or synthetic compounds and their biological activities, and so on. Compound Libraries like natural product libraries are powerful tools for cell induction research focused on unique natural structures along with new bioactivity.
Other Chemical Research: In addition to the application areas mentioned above, Compound Libraries can be used for other chemical studies. Primarily, this refers to chemistry research in other fields outside of the pharmaceutical industry.
2. Global Compound Libraries Market Revenue by Application
In 2018, the High Throughput Screening segment generated a revenue of $128.52 million, which escalated to $277.78 million in 2023, reflecting a substantial growth rate. This surge can be attributed to the increasing demand for efficient drug discovery processes and the pivotal role HTS plays in the early stages of drug development.
Common drug design follows as the second leading application, with a revenue of $82.65 million in 2018 that grew to $188.35 million by 2023. This application has been instrumental in the innovative process of discovering new medications based on the knowledge of a biological target, underlining the importance of advanced technologies like artificial intelligence and automation in drug design.
Medicinal chemistry and research represent another significant application, starting with $35.63 million in 2018 and reaching $79.28 million in 2023. This growth underscores the continuous efforts in creating and refining molecules to improve drugs and understand their interactions with biological systems.
Other chemical research, although the smallest segment, has also shown a steady increase from $31.99 million in 2018 to $66.31 million in 2023. This category includes a broad range of chemical studies outside the pharmaceutical industry, highlighting the diverse utility of compound libraries.
In summary, the compound libraries market has experienced a consistent upward trend across all applications, indicating the expanding utility and importance of these libraries in chemical and biological research, drug discovery, and development. The market’s growth is expected to continue, driven by technological advancements and the increasing need for efficient and targeted drug development methodologies.
Table Global Compound Libraries Revenue (M USD) by Applications (2018-2023)
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
High Throughput Screening | 128.52 | 149.02 | 171.88 | 211.24 | 244.56 | 277.78 |
Common Drug Design | 82.65 | 94.65 | 112.21 | 140.42 | 163.41 | 188.35 |
Medicinal Chemistry and Research | 35.63 | 40.99 | 48.31 | 59.92 | 69.48 | 79.28 |
Other Chemical Research | 31.99 | 36.55 | 43.28 | 51.74 | 58.91 | 66.31 |
Total | 278.79 | 321.20 | 375.68 | 463.34 | 536.36 | 611.72 |
Over the period from 2018 to 2023, these applications have shown a notable distribution in terms of revenue contribution to the overall market.
High Throughput Screening has consistently held the largest share, starting at 46.10% in 2018 and slightly decreasing to 45.41% by 2023. This indicates the pervasive use of compound libraries in the initial phases of drug discovery where rapid testing of large numbers of compounds is required.
Common Drug Design follows as the second significant application, with its share increasing from 29.65% in 2018 to 30.79% in 2023. This growth underscores the importance of compound libraries in the innovative process of designing new medications based on the understanding of biological targets.
Medicinal Chemistry and Research also captures a significant portion of the market, with a stable share over the years, starting at 12.78% in 2018 and increasing marginally to 12.96% in 2023. Other Chemical Research, while the smallest segment, has maintained a relatively steady share, decreasing slightly from 11.47% in 2018 to 10.84% in 2023.
In summary, the compound libraries market’s revenue distribution across applications highlights the importance of High Throughput Screening and drug design, with a steady contribution from medicinal chemistry and research, and a niche but consistent role in other chemical research domains.
Table Global Compound Libraries Revenue Share by Applications (2018-2023)
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
High Throughput Screening | 46.10% | 46.39% | 45.75% | 45.59% | 45.60% | 45.41% |
Common Drug Design | 29.65% | 29.47% | 29.87% | 30.31% | 30.47% | 30.79% |
Medicinal Chemistry and Research | 12.78% | 12.76% | 12.86% | 12.93% | 12.95% | 12.96% |
Other Chemical Research | 11.47% | 11.38% | 11.52% | 11.17% | 10.98% | 10.84% |
Total | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
3. Global Compound Libraries Market Forecast by Application
High Throughput Screening is anticipated to maintain its dominant position, with revenues projected to increase from $277.78 million in 2023 to an estimated $554.24 million by 2028, reflecting a CAGR of 14.81%. This growth is driven by the technology’s ability to rapidly evaluate large numbers of compounds, which is crucial for early-stage drug discovery.
Common Drug Design is also expected to experience significant growth, with revenues rising from $188.35 million in 2023 to a projected $405.30 million by 2028, showcasing a CAGR of 16.56%. This application’s growth can be attributed to the increasing need for innovative drug design methodologies that can expedite the development of new medications.
Medicinal Chemistry and Research is forecasted to grow from $79.28 million in 2023 to $168.35 million by 2028, with a CAGR of 16.26%. This growth underscores the importance of compound libraries in the synthesis and refinement of molecules, which is vital for drug improvement and understanding their biological activities.
Other Chemical Research, while starting from a lower base, is also projected to increase from $66.31 million in 2023 to $132.60 million by 2028, indicating a CAGR of 14.87%. This segment’s growth highlights the expanding utility of compound libraries in a broader range of chemical research beyond the pharmaceutical domain.
In summary, the compound libraries market is set to experience substantial growth across all application segments, with High Throughput Screening and Common Drug Design leading the way, driven by the increasing demand for efficient drug discovery and development processes, technological advancements in screening techniques, and the continuous pursuit of novel therapeutics to address global health challenges.
Table Global Compound Libraries Revenue (M USD) Forecast by Applications (2023-2028)
| 2023 | 2024F | 2025F | 2026F | 2027F | 2028F |
High Throughput Screening | 277.78 | 321.80 | 367.46 | 422.57 | 486.96 | 554.24 |
Common Drug Design | 188.35 | 220.80 | 254.50 | 298.07 | 348.62 | 405.30 |
Medicinal Chemistry and Research | 79.28 | 92.32 | 106.50 | 124.12 | 145.25 | 168.35 |
Other Chemical Research | 66.31 | 76.63 | 87.38 | 100.72 | 116.58 | 132.60 |
Total | 611.72 | 711.55 | 815.83 | 945.47 | 1097.41 | 1260.48 |
High Throughput Screening is anticipated to maintain the largest market share, with its proportion slightly decreasing from 45.41% in 2023 to 43.97% by 2028. Common Drug Design is projected to see its share increase from 30.79% in 2023 to 32.15% by 2028. Medicinal Chemistry and Research is also expected to grow its share, expanding from 12.96% in 2023 to 13.36% by 2028. Other Chemical Research, while starting from a smaller base, is forecasted to increase its share from 10.84% in 2023 to 10.52% by 2028.
In summary, the compound libraries market is expected to see a shift in market share across applications, with High Throughput Screening leading, followed by Common Drug Design and Medicinal Chemistry and Research. The forecasted changes in market share reflect the evolving landscape of drug discovery and development, where compound libraries play a pivotal role in accelerating the process and enhancing efficiency.
Table Global Compound Libraries Market Share Forecast by Applications (2023-2028)
| 2023 | 2024F | 2025F | 2026F | 2027F | 2028F |
High Throughput Screening | 45.41% | 45.23% | 45.04% | 44.69% | 44.37% | 43.97% |
Common Drug Design | 30.79% | 31.03% | 31.19% | 31.53% | 31.77% | 32.15% |
Medicinal Chemistry and Research | 12.96% | 12.97% | 13.05% | 13.13% | 13.24% | 13.36% |
Other Chemical Research | 10.84% | 10.77% | 10.71% | 10.65% | 10.62% | 10.52% |
Total | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
